معرفی
Professor Danijela Gnjidic is affiliated with the Sydney Pharmacy School at the University of Sydney, serving as Interim Deputy Associate Dean of Research in the Faculty of Medicine and Health. She leads the Clinical Practice Guideline for Deprescribing Opioid Analgesics and is a member of the Charles Perkins Centre.
- Education: PhD (University of Sydney, 2010), MPH (concurrent with PhD), BSc (Hons)
- International Collaborations: Ghent University (Belgium), Karolinska Institute (Sweden), University of Kentucky and Yale University (USA)
Research Focus: Her work spans Geriatric Pharmacology, Deprescribing, Pharmacoepidemiology, and Quality Use of Medicines, with specific emphasis on:
- Dementia and Medication Management
- Frailty Assessment in Older Adults
- Opioid Safety and Chronic Pain
- Drug Burden Index and Polypharmacy
- Clinical Guidelines for Deprescribing
- Healthcare Implementation Strategies
Recent Publications analyze trends in opioid deprescribing, frailty measurement, adverse drug reactions, and technology-driven medication management, reflecting interdisciplinary approaches combining geriatrics, epidemiology, and health informatics.
Awards include the Thompson Fellowship (2023), NHMRC Dementia Leadership Fellowship (2017-21), and multiple accolades for mentorship and leadership in Geriatric Pharmacology.
Teaching & Supervision: Coordinates Honours Unit of Study in Pharmacotherapeutics, Public Health, and Evidence-Based Medicine. Supervises projects on dementia care and medication optimization.
Associations: Past President of ASCEPT, Deputy Chair of HDR Examinations Subcommittee, and editorial roles for British Journal of Clinical Pharmacology and PLOS One.
